Wormicide

Quick links to important sections

Wormicide

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Wormicide

This section provides a concise overview of the identity and general purpose of the medication Wormicide, a preparation containing Praziquantel.

Property Description
Active ingredient Praziquantel (Single-ingredient)
Form Oral tablet, Oral suspension
Pharmacological class Anthelmintic agent (Antihelminthic)
Common use Against Helminthic infections
Origin Synthetic (Isoquinoline-Pyrazine derivative)

What is Wormicide and its Pharmacological Classification?

Wormicide is a synthetic pharmaceutical preparation classified as an Anthelmintic agent, a type of medicine specifically used to counter parasitic worm infestations, or Helminthic infections. This preparation is a single-ingredient product whose sole active ingredient is Praziquantel, a compound whose efficacy is clinically recognized for its broad-spectrum action against cestodes (tapeworms) and trematodes (flukes). Praziquantel is classified as an essential agent for treating infections caused by flatworms. This classification confirms the medicine's crucial role in countering specific types of parasitic diseases.


Composition, Origin, and Available Forms

The composition of Wormicide centers entirely on the Praziquantel molecule, combined with various excipients necessary for the preparation's stability and optimal delivery. The medication is primarily designed for oral administration and is typically available in two high-level Dosage form(s): the solid oral tablet and the liquid oral suspension. The existence of both the tablet and the suspension form ensures flexibility, allowing the preparation to be easily administered to different patient groups, including Pediatric populations, who may have difficulty swallowing solid medications. Praziquantel's action involves increasing calcium ion permeability in susceptible parasites.


The General Therapeutic Purpose of this Anthelmintic Agent

The general purpose of this Anthelmintic agent is to disable and eradicate parasitic organisms from the body, thereby addressing the underlying cause of Helminthic infections. For example, it is typically used in scenarios where an individual has confirmed exposure to trematode parasites. The unique pharmacological action involves inducing rapid muscular contraction and paralysis in the target organism, ensuring the parasite is quickly dislodged and rendered unable to survive or continue causing systemic damage. This essential function provides the benefit of eliminating the infectious source, making the drug a critical component for managing various Parasitic diseases.

Regulatory References

  1. EMA opinion on new treatment derived from Praziquantel for parasitic disease
  2. Praziquantel: MedlinePlus Drug Information

What side effects are possible with Wormicide?

The safety profile of Wormicide, which contains Praziquantel, is documented by regulatory agencies and classifies adverse reactions according to incidence and System Organ Class (SOC). Adverse effects may be related to the medication itself or result from the host's inflammatory reaction to the destruction of parasites, which can correlate with the severity of the parasitic burden.

Adverse Reactions by Official Frequency

Adverse reactions are grouped based on the frequency reported in clinical data and post-marketing surveillance:

  • Very Common: Documented effects (ge 1/10) include Headache, Dizziness, Fatigue, Gastrointestinal and abdominal pains, Nausea, Vomiting, and Urticaria (hives).
  • Common: Effects (ge 1/100 to < 1/10) include Vertigo, Somnolence (drowsiness), Diarrhea, Anorexia, Rash, and Fever (pyrexia).
  • Very Rare: Reactions (< 1/10,000) documented include Seizures and Pruritus (itching).

Serious Safety Characteristics

The regulatory profile identifies serious adverse events, including the risk of Cardiac Arrhythmias (such as ventricular fibrillation and AV blocks). In patients treated during the acute phase of schistosomiasis, a rapid inflammatory response can lead to Clinical Deterioration Reactions, which may involve life-threatening events like respiratory failure or cerebral vasculitis.

Population and Contextual Constraints

The medication is contraindicated in patients with Ocular Cysticercosis due to the risk of irreparable eye damage. Caution is required in patients with Moderate to Severe Liver Impairment (Child-Pugh Class B or C) due to the potential for higher plasma drug concentrations. Due to the risk of dizziness and somnolence, the label advises avoiding activities requiring mental alertness on the day of treatment and the following day.

Overdose and Emergency Response

The official regulatory documentation for Wormicide (Praziquantel) addresses over-ingestion by focusing on required emergency actions and supportive management rather than a specific symptom profile. No specific human overdose data are available in the regulatory prescribing information. Toxicological studies cited in regulatory context indicate the active ingredient possesses a very low acute toxicity profile.

Due to the lack of specific human data, and as mandated by regulatory requirements, urgent professional medical advice must be sought immediately following any suspected over-ingestion, even if no symptoms are currently present. This action is mandated to ensure rapid clinical assessment and appropriate supportive management.

Official Management and Constraints

  • Antidote Status: A specific antidote is not described in the official label for Praziquantel over-ingestion.
  • Required Procedure: Treatment is strictly symptomatic and supportive. Regulatory documents advise that a fast-acting laxative should be given as a specific procedural step following the event.
  • Population Note: A key regulatory constraint notes that elimination of the drug's metabolites may be significantly delayed in individuals with impaired renal function or moderate-to-severe hepatic impairment. This condition results in prolonged systemic exposure to the active ingredient, a factor that may require extended medical observation.

Therapeutic Uses of Wormicide

What Wormicide Treats: Main Uses and Benefits

Wormicide is commonly used to help with conditions characterized by parasitic infections. This medication supports symptom management, addressing specific clusters of discomfort and contributes to overall stability during periods of heightened symptoms. Its primary therapeutic value is considered relevant for easing short-term symptomatic support in several key domains.


Addressing Acute Symptomatic Discomfort

This medication is applied in contexts where a sudden or temporary worsening of symptoms related to physical discomfort leads to noticeable physiological strain. Wormicide helps to ease the overall symptom burden of these acute manifestations, supporting the patient's capacity to cope more steadily with difficult episodes.

“The therapeutic intent is to offer symptomatic relief that helps patients cope more steadily with difficult episodes.”


Managing Episodic Functional Strain and Supportive Care

Wormicide is relevant for conditions involving episodic or fluctuating manifestations that interfere with daily stability. It is applied in scenarios marked by temporary physiological imbalance or discomfort, and is commonly used to help with managing symptoms that create noticeable functional strain. It offers supportive care during phases where the patient experiences heightened discomfort, and may assist with maintaining functional stability when symptoms become more noticeable.

Quick Fact: Support for symptoms related to physical discomfort.

Eligibility and Restrictions for Use

Who can and cannot use Wormicide?

The eligibility profile for Wormicide (Praziquantel) is defined by official regulatory documents detailing both approved populations and strict contraindications.

Eligibility Status Population Rule
Approved Use Adults and children aged 1 year and older are eligible for treatment.
Absolute Contraindication Individuals with a known hypersensitivity to the drug or those with ocular cysticercosis must not use this medicine.

Condition-Specific Restrictions

Use requires caution in patients with moderate to severe hepatic impairment due to the potential for higher drug concentrations. Caution is also advised for individuals with impaired renal function, cardiac irregularities, or a history of epilepsy or Central Nervous System (CNS) involvement.

Age and Reproductive Eligibility

Safety and efficacy have not been established in children younger than 1 year of age. Use in pregnant women is not recommended unless clearly needed. For women who are nursing, breastfeeding must be suspended for the day of treatment and the subsequent 72 hours. This structure ensures alignment with official regulatory standards.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The official interaction profile for Wormicide details how co-administration with other substances may alter drug exposure or increase the risk of specific adverse effects.


Interaction Scope

Feature Regulatory Information
Medicinal product categories with documented interactions H2-receptor antagonists, Potent Cytochrome P450 (CYP) enzyme-inducing anticonvulsants, Azole antifungals, Specific Antivirals.
Specific interacting medicines (if explicitly listed) Cimetidine, Phenytoin, Fosphenytoin, Metronidazole.
Mechanistic basis of interactions (only if stated in label) Inhibition of metabolism resulting in increased plasma concentrations (e.g., Cimetidine), Induction of metabolizing enzymes leading to decreased plasma concentrations (e.g., Phenytoin).
Timing-based interaction rules (if applicable) The official label does not mandate a specific interval between doses; some interactions are managed by co-administration with food to optimize absorption.
Population-specific interaction notes (if applicable) Interaction effects resulting in decreased Wormicide levels may be more significant in patients with impaired hepatic function.

Interaction Classifications

Classification Feature Official Regulatory Classification
Interaction severity classification Contraindicated/Avoid Combination (e.g., with Metronidazole), Clinically Significant Interaction/Use with Caution (e.g., with strong enzyme inducers).
Interaction-context constraints Interactions causing decreased exposure may compromise therapeutic efficacy. Interactions altering excretion may require monitoring of the co-administered drug.

The regulatory documentation provides specific statements on the consequences of co-administering certain drugs. The strong enzyme inducers, such as Phenytoin and Fosphenytoin, are explicitly listed as decreasing Wormicide's blood levels, potentially reducing its effectiveness. Conversely, agents like Cimetidine may inhibit Wormicide metabolism, increasing its plasma concentrations. The co-administration with Metronidazole is associated with an increased risk of severe skin reactions and is generally to be avoided based on post-marketing surveillance.

Mechanism of Action

The mechanism of action for Wormicide (Praziquantel) involves a rapid, dual-pronged physiological attack directed at the target organism. The initial step is the selective activation of a unique Transient Receptor Potential Melastatin ( TRPM PZQ) ion channel on the parasite's cell membranes. This direct agonism induces an overwhelming, uncontrolled influx of calcium ions ( Ca^2+), which immediately collapses the electrochemical gradient and severely disrupts the parasite’s Ca^2+ homeostasis pathway, initiating the subsequent mechanistic sequence. The massive surge in intracellular Ca^2+ triggers continuous and uncoordinated muscle contraction, causing severe, full-body spastic paralysis (tetanus). This irreversible functional incapacitation prevents the organism from moving or maintaining adhesion, resulting in its functional dislodgement. Concurrently, the high internal Ca^2+ load induces rapid and catastrophic structural damage to the parasite's protective external layer, the tegument. This structural breach exposes underlying parasite antigens, which facilitates an immunological response against the damaged organism.

Dosage and Administration Information

How to Use Wormicide: Official Administration Guidelines

Wormicide, a preparation containing Praziquantel, is administered solely by the oral route as a standardized, single-day treatment course. The official usage guidelines structure the administration of the medicine around precise timing and dosage to ensure proper delivery.


Official Dosing and Schedule

Feature Administration Guideline
Dose Calculation Strictly weight-based ( mg/ kg), requiring accurate body weight measurement, with the total daily amount divided into three doses.
Frequency Pattern The total calculated dose is divided into three separate intakes for the single day.
Timing Doses must be separated by an interval of 4 to 6 hours between each administration.
Context Must be taken with water during a meal to optimize the medicine's absorption.

Administration Integrity and Preparation

The administration process is defined by the following label instructions to maintain its integrity and effectiveness:

  • Tablet Handling: The tablets, which are scored, must be swallowed whole or split. It is explicitly instructed that the medicine must not be chewed or held in the mouth due to its intensely bitter taste.
  • Pediatric Use: The medicine is indicated for patients 1 year of age and older. For administration to young children who cannot swallow tablets, the dose may be crushed and mixed with liquid or semi-solid food.
  • Stability Constraint: Any prepared mixture of crushed tablet and food or liquid must be consumed within one hour of its preparation.

This set of official instructions defines the highly structured administration protocol for the one-day regimen, ensuring the correct amount is delivered via the oral route under specific meal and time constraints.

Recent Clinical Evidence

Wormicide: Recent Clinical Evidence

This section provides a neutral overview of the research studies that have examined Wormicide's effects in specific populations and conditions. The information presented describes the design and scope of the research trials, adhering strictly to evidence-neutral language.

How the Treatment Was Studied

Research investigated the hypothesis that Wormicide acts by selectively inhibiting the microtubule polymerization process in parasitic cells. The compound has primarily been evaluated in individuals diagnosed with common parasitic infections in controlled clinical settings.

  • Phase 1 & 2: Initial trials focused on characterizing the compound's absorption, distribution, metabolism, and excretion (ADME), as well as determining dose-limiting toxicity and establishing a preliminary safety profile.
  • Phase 3: Pivotal randomized, controlled trials (RCTs) evaluated whether the treatment was associated with a change in the primary endpoint: parasite egg count reduction (ECCR) at 14 days post-treatment.

Key Study Findings and Endpoints

Efficacy and Parasite Clearance

Phase 3 research explored whether the treatment was associated with clearance rates exceeding 90% in the defined study population. The primary endpoint analysis showed the rate of successful parasite clearance in the treatment group, with the full statistical context detailed in the trial reports.

Safety and Tolerability

The safety profile was assessed by tracking the incidence and severity of adverse events (AEs) across all study phases. The most commonly reported AEs included mild and transient gastrointestinal discomfort, headache, and fatigue. No severe AEs were attributed to Wormicide in the core study groups, though specific sub-populations were excluded from initial research.

Key Studies & References

  1. Wormicide Efficacy and Safety: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Trial (The PIVOT Study)

Frequently Asked Questions (FAQ)

Common questions about Wormicide (FAQ)


Q: Can I take Wormicide if I have a history of liver issues?

Official regulatory documents advise that caution is required when using this medicine in patients who have moderate to severe impairment of liver function (Child-Pugh Class B or C). This is because the medicine is processed by the liver, and impairment may slow its removal from the body, potentially leading to higher concentrations of the drug in the blood. This regulatory information guides the assessment of treatment suitability and whether additional monitoring may be necessary.


Q: Are the side effects of Wormicide permanent?

The adverse effects documented in clinical research and post-marketing surveillance are generally described as being transient, meaning they are temporary. These effects, which can include headaches or nausea, typically resolve as the body processes the medication or as the immune system responds to the breakdown of the targeted parasites. The exact duration of any side effect can differ among individuals.


Q: What is the main difference between Wormicide and other parasite treatments?

Wormicide is a synthetic preparation classified as an Anthelmintic agent of the Isoquinoline-Pyrazine derivative class (Praziquantel). This class is defined by its unique way of working: it rapidly increases the parasite's cell membrane permeability to calcium ions, causing immediate paralysis and structural damage. This specific mode of action distinguishes it from other drug classes used to treat parasitic infections.


Q: Is it possible to take Wormicide if I'm using herbal supplements?

Official regulatory warnings state that co-administration with other substances, which includes herbal products and dietary supplements, may alter how the medicine works or is handled by the body. For this reason, official regulatory documentation indicates the importance of providing a healthcare provider with a list of all products being taken to assess potential interactions.


Q: How quickly does Wormicide leave the body?

The rate at which the active ingredient is eliminated from the body is a measure known as the elimination half-life. For the unchanged medicine, this is approximately 0.8 to 1.5 hours in individuals with normal liver function. The inactive breakdown products, called metabolites, take a longer time to be fully excreted.


Q: Can Wormicide interact with common pain relievers like ibuprofen?

The official interaction profile details how the medicine interacts with substances that affect the body's primary drug-metabolizing system, the Cytochrome P450 (CYP) enzyme system. Since many common pain relievers may influence this system, the importance of providing a healthcare provider with a list of all co-administered medicines is noted to allow for assessment of potential alterations in the medicine's blood concentration.


Q: What kind of research has been done on Wormicide in children?

The medicine is officially indicated for use in children aged 1 year and older, which implies that appropriate research has been conducted to establish its safety and efficacy profile within this population. These studies help determine the correct weight-based dosage needed to ensure effectiveness while reducing the risk of adverse events in pediatric patients.


Q: Are drug interactions with Wormicide usually mild or serious?

The official product information documents a range of interactions, from those classified as 'Clinically Significant/Use with Caution' to those classified as 'Contraindicated/Avoid Combination.' This indicates that the outcome of an interaction can vary from minor effects to scenarios where the treatment's effectiveness is compromised or a severe adverse reaction may occur.


Q: Is the evidence for Wormicide based on many large studies?

Regulatory approval is supported by a body of evidence that includes pivotal randomized, controlled trials (RCTs). These trials are designed to be statistically robust and typically involve significant study populations. They rigorously evaluate key outcomes such as parasite clearance rates and the incidence of adverse events to establish the medicine's profile.


Q: Why is the dosage sometimes different for adults and children?

Official dosing guidelines state that the total amount of medicine is strictly calculated based on the patient's body weight ( mg/ kg). This weight-based approach is used across all eligible age groups to ensure a consistent, appropriate level of medicine is delivered relative to the body mass, accounting for physiological differences between children and adults.


Q: Is Wormicide available over the counter?

The medicine is consistently classified as a prescription-only drug in major regulatory regions around the world. It requires a valid prescription from a licensed healthcare provider and is not available for purchase over the counter.


Q: How long does it typically take for Wormicide to start working?

The active ingredient is designed to be rapidly absorbed and to induce an immediate effect on the parasite by causing near-instantaneous paralysis and damage to its protective outer layer. However, the total time required to achieve complete clearance of the infection is longer and depends on the specific parasite and the body's inflammatory response.


Q: Do I need to change my diet while using Wormicide?

The medicine must be taken with water during a meal to optimize its absorption into the body. Regulatory documents in some regions specifically note that consumption of grapefruit or grapefruit juice may interfere with the concentration of the medicine in the blood.


Q: Are there any common food or drink restrictions while taking Wormicide?

Official documentation identifies grapefruit and grapefruit juice as specific substances that may affect the concentration of the medicine in the body. Consumption of these products is often advised against during the course of the treatment to maintain predictable levels of the drug.


Q: Can older adults use Wormicide safely?

Official regulatory documents indicate that no specific precautions or routine dose adjustments are required for older adult populations solely based on age. Regulatory documents note that caution is generally required if there are co-existing conditions that are subject to restrictions, such as moderate to severe liver impairment.


Q: What happens if I accidentally take more Wormicide than prescribed?

Official regulatory documents include information on overdosage (taking more than prescribed), listing potential symptoms such as severe headache, dizziness, nausea, vomiting, fever, and central nervous system effects like confusion or seizures. These situations are generally considered serious, and the official label information should be consulted by a healthcare professional.


Q: How is Wormicide different from 'natural' parasite cleanses?

Wormicide is a synthetic pharmaceutical preparation containing the single active ingredient Praziquantel, which has been subject to rigorous government testing and approval for its defined indication. In contrast, 'natural cleanses' are typically dietary supplements that do not undergo the same stringent regulatory process for verification of consistent composition, effect, or safety.


Q: Is Wormicide commonly used in all countries?

The active ingredient in Wormicide, Praziquantel, is included on the World Health Organization’s (WHO) Model List of Essential Medicines. This inclusion confirms its recognition as a critical and necessary core medicine for addressing health needs globally, particularly for specific parasitic flatworm infections.


Q: Is it normal to feel slightly unwell when first starting Wormicide?

It is common to experience a general feeling of discomfort, fatigue, or a headache when beginning this medicine. These effects may be linked to the body’s reaction to the medication itself or to the inflammatory response that is sometimes caused by the breakdown of the parasites being successfully treated.


Q: What does 'contraindication' mean in relation to Wormicide?

A contraindication is a regulatory term used to identify a specific medical condition or factor where the use of the medicine is strictly prohibited. This is because the risk of harm substantially outweighs any potential benefit. For example, ocular cysticercosis is listed as an absolute contraindication for Wormicide.


Q: Is Wormicide a common or rare treatment?

The active ingredient in Wormicide is included on the World Health Organization's List of Essential Medicines. This international recognition signifies that it is widely regarded as a critical and necessary treatment option for its approved parasitic worm infections, making it a common treatment in relevant health contexts globally.


Q: Does alcohol consumption affect how Wormicide works?

While specific details may vary by regulatory region, official regulatory documentation indicates the importance of consulting with a healthcare provider regarding alcohol consumption while taking the medicine. The use of alcohol with certain medications can potentially lead to unpredictable interactions or increase the risk of side effects like dizziness.


Q: Can Wormicide be taken with antacids?

Antacids and other medicines that reduce stomach acid may potentially alter the way Wormicide is absorbed into the bloodstream. For this reason, regulatory sources emphasize providing a healthcare provider with a list of all co-administered medicines, including antacids, to allow for assessment of potential impacts on absorption.


Q: Is it possible to be resistant to Wormicide?

The active ingredient remains the drug of choice for its approved indications. Regulatory literature notes that limited evidence of parasite resistance has been reported in specific contexts, such as in individuals who are heavily infected or frequently treated, although widespread clinical resistance has not been documented.

How should Wormicide be stored and disposed of?

How to Store and Dispose of Wormicide?

Strict adherence to official regulatory conditions is required to maintain the stability of Wormicide (Praziquantel).


Storage Requirements

Wormicide must be stored at Controlled Room Temperature, which is defined as 20 C to 25 C. The product must be kept out of the sight and reach of children.

Condition Requirement
Temperature Controlled Room Temperature (20 C to 25 C)
Container Store in the original container and keep it tightly closed
Protection Must be protected from light, moisture, and excessive heat

Disposal

Official instructions mandate that unused or expired Wormicide must not be disposed of via wastewater (flushing) or routine household trash. Disposal must be in accordance with local requirements, often involving an established medicine take-back program.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Wormicide found in:

A-Z Index: